AD 121
Alternative Names: AD121; PW 9101Latest Information Update: 18 Feb 2004
At a glance
- Originator Penwest Pharmaceuticals; Sosei R&D
- Developer Sosei R&D
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 02 Feb 2004 Discontinued - Phase-I/II for Rheumatoid arthritis in United Kingdom (PO)
- 29 Nov 2000 Phase-I/II clinical trials for Rheumatoid arthritis in United Kingdom (PO)